Evaluation of endocrine tests. C: Glucagon and clonidine test in phaeochromocytoma

Netherlands Journal of Medicine

Volumn 67, Issue 3, 2009, Pages 91-95

  Bisschop, P H ^a   Corssmit, E P M ^b   Baas, S J ^a   Serlie, M J ^a   Endert, E ^a   Wiersinga, W M ^a   Fliers, E ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Clonidine; Glucagons; Phaeochromocytoma

Indexed keywords

CATECHOLAMINE; CLONIDINE; GLUCAGON; METADRENALIN; NORMETADRENALIN;

ADULT; AGED; ARTICLE; CATECHOLAMINE BLOOD LEVEL; CATECHOLAMINE URINE LEVEL; CLINICAL TRIAL; CLONIDINE SUPPRESSION TEST; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENDOCRINE FUNCTION TEST; FEMALE; FOLLOW UP; GLUCAGON STIMULATION TEST; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; PHEOCHROMOCYTOMA; SENSITIVITY AND SPECIFICITY;

ADRENAL GLAND NEOPLASMS; ADULT; AGED; CATECHOLAMINES; CLONIDINE; FEMALE; GLUCAGON; HUMANS; MALE; MIDDLE AGED; PHEOCHROMOCYTOMA;

EID: 63049105921     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Stenstrom G, Svardsudd K. Pheochromocytoma in Sweden 1958-1981. An analysis of the National Cancer Registry Data. Acta Med Scand. 1986;220:225-32.
2. Gifford RW, Kvale WF, Maher FT, Roth GM, Priestley JT. Clinical features, diagnosis and treatment of pheochromocytoma: a review of 76 cases. Mayo Clin Proc. 1964;39:281-302.
3. Sheps SG, Maher FT. Histamine and glucagon tests in diagnosis of pheochromocytoma. JAMA. 1968;205:895-9.
4. Lenders JWM, Pacak K, Walther MM et al. Biochemical Diagnosis of Pheochromocytoma: Which Test Is Best? JAMA. 2002;287:1427-34.
5. Grossman E, Goldstein DS, Hoffman A, Keiser HR. Glucagon and clonidine testing in the diagnosis of pheochromocytoma. Hypertension. 1991;17:733-41.
6. Bravo EL, Gifford RW, Jr. Current concepts. Pheochromocytoma: diagnosis, localization and management. N Engl J Med. 1984;311:298-303.
7. Bravo EL. Evolving concepts in the pathophysiology, diagnosis, and treatment of pheochromocytoma. Endocr Rev. 1994;15:356-68.
8. Van der Hoorn FA, Boomsma F, Man in 't Veld AJ, Schalekamp MA. Determination of catecholamines in human plasma by high-performance liquid chromatography: comparison between a new method with fluorescence detection and an established method with electrochemical detection. J Chromatogr. 1989;487:17-28.
9. Elliott WJ, Murphy MB. Reduced specificity of the clonidine suppression test in patients with normal plasma catecholamine levels. Am J Med. 1988;84:419-24.
10. Lenz T, Ross A, Schumm-Draeger P, Schulte KL, Geiger H. Clonidine Suppression Test Revisited. Blood Press. 1998;7:153-9.
11. Eisenhofer G, Goldstein DS, Walther MM, et al. Biochemical Diagnosis of Pheochromocytoma: How to Distinguish True- from False-Positive Test Results. J Clin Endocrinol Metab. 2003;88:2656-66.
12. Sjoberg RJ, Simcic KJ, Kidd GS. The clonidine suppression test for pheochromocytoma. A review of its utility and pitfalls. Arch Intern Med. 1992;152:1193-7.